KalVista Pharmaceuticals, Inc. ($KALV)
Venrock Healthcare Capital Partners III, L.P. โ 10% Owner
Shares
174,485
Price
$16.95
Total Value
$2,957,520.75
Nearby Earnings
Mar 24, 2026
EPS:Est: -0.54
Revenue:Est: $32.29M
Mar 25, 2026
EPS:Est: -0.53
Revenue:Est: $32.29M
Transaction Details
| Insider | Venrock Healthcare Capital Partners III, L.P. |
|---|---|
| Title | 10% Owner |
| Transaction Date | Mar 25, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Indirect |
| Nature of Ownership | By Funds |
| Filing Date | Mar 27, 2026 |
| Shares Sold | 174,485 |
| Price per Share | $16.95 |
| Total Value | $2,957,520.75 |
| Shares Owned After | 5,129,500 |
| Derivative | No |
| Accession Number | 0001231919-26-000286 |
| Document | View SEC Filing |